Mithra logo.jpg
Mithra Provides an Update in the Context of Recent Market Developments
05 oct. 2023 01h00 HE | Mithra Pharmaceuticals
Mithra Provides an Update in the Context of Recent Market Developments Financial results show Mithra has solid financial foundation and multiple options to financeShareholder meetings called to...
Advicenne.jpg
Advicenne receives positive feedback from the US FDA on pathway to approval and amended Phase III study protocol for its treatment of distal renal tubular acidosis (dRTA)
17 mai 2021 12h03 HE | Advicenne
Advicenne receives positive feedback from the US FDA on pathway to approval and amended Phase III study protocol for its treatment of distal renal tubular acidosis (dRTA) FDA accepts amended protocol...
Advicenne.jpg
Advicenne reçoit un avis positif de la FDA sur la procédure d'approbation et l’Agence accepte le protocole modifié de l'étude de phase III pour son traitement de l'acidose tubulaire rénale distale (ATRd)
17 mai 2021 12h00 HE | Advicenne
Advicenne reçoit un avis positif de la FDA sur la procédure d'approbation et l’Agence accepte le protocole modifié de l'étude de phase III pour son traitement de l'acidose tubulaire rénale distale...